Gaml-Sørensen, A., Frølich, M. K.
, Brix, N., Ernst, A., Bonde, J. P. E., Hougaard, K. S., Tøttenborg, S. S.
, Clemmensen, P. J., Toft, G. & Ramlau-Hansen, C. H. (2024).
Sleep duration and biomarkers of fecundity in young men: a cross-sectional study from a population-based cohort.
Andrology,
12(5), 1125-1136. Article 13560.
https://doi.org/10.1111/andr.13560
Villumsen, B., Frystyk, J., Jørgensen, M. G., Hørdam, B.
& Borre, M. (2024).
Exergaming Improves Cardiac Risk Factors in Prostate Cancer Patients: A Single-Blinded Randomized Controlled Trial.
Games for Health,
13(2), 93-99.
https://doi.org/10.1089/g4h.2023.0096
Skott, M., Genech, M., Hoen, L. A. ., Kennedy, U., Van Uitert, A., Zachou, A., Yuan, Y., Quaedackers, J., Silay, M. S.
, Rawashdeh, Y. F., Burgu, B., Castagnetti, M., O'Kelly, F., Bogaert, G. & Radmayr, C. (2024).
Endoscopic dilatation/incision of primary obstructive megaureter: A systematic review. On behalf of the EAU paediatric urology guidelines panel.
Journal of Pediatric Urology,
20(1), 47-56.
https://doi.org/10.1016/j.jpurol.2023.09.005
Wallace, E.
, Jensen, B. T., Ahern, C.
& Rasmussen, S. A. (2023).
Continence Care. In H. Maderbacher (Ed.),
Handbook of Neurourology: Theory and Practice, Second Edition (2 ed., pp. 325-341). Springer Nature.
https://doi.org/10.1007/978-981-99-1659-7_77,
https://doi.org/10.1007/978-981-99-1659-7_77Lauridsen, S. V., Jensen, B. T., Tønnesen, H., Dalton, S. O.
& Rasmussen, M. (2023).
The gold standard program (GSP) for smoking cessation: a cohort study of its effectiveness among smokers with and without cancer.
Acta Oncologica,
62(7), 774-781.
https://doi.org/10.1080/0284186X.2023.2228445
Fode, M.
, Rawashdeh, Y. F. H., Jakobsen, L. K., Haase, R. N., Poulsen, A. M. & Azawi, N. H. (2023).
Rekonstruktiv urologi.
Ugeskrift for Læger,
185(7/A), 697-699. Article V09220578.
Lindskrog, S. V., Birkenkamp-Demtröder, K., Nordentoft, I. K., Laliotis, G.
, Lamy, P., Christensen, E., Renner, D.
, Andreasen, T. G., Lange, N., Sharma, S., ElNaggar, A. C., Liu, M. C., Sethi, H., Aleshin, A.
, Agerbæk, M., Jensen, J. B. & Dyrskjøt, L. (2023).
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.
Clinical Cancer Research,
29(23), 4797-4807.
https://doi.org/10.1158/1078-0432.CCR-23-1860
Lyskjær, I., Iisager, L., Axelsen, C. T.
, Nielsen, T. K., Dyrskjøt, L. & Fristrup, N. (2024).
Management of renal cell carcinoma: promising biomarkers and the challenges to reach the clinic.
Clinical Cancer Research,
30(4), 663-672.
https://doi.org/10.1158/1078-0432.CCR-23-1892
Levinsen, A. K. G., Kjaer, T. K., Thygesen, L. C., Maltesen, T., Jakobsen, E., Gögenur, I.
, Borre, M., Christiansen, P., Zachariae, R., Christensen, P., Laurberg, S., de Nully Brown, P., Hölmich, L. R., Johansen, C., Kjær, S. K., van de Poll-Franse, L., Saltbæk, L. & Dalton, S. O. (2023).
Social inequality in cancer survivorship: Educational differences in health-related quality of life among 27,857 cancer survivors in Denmark.
Cancer Medicine,
12(19), 20150-20162.
https://doi.org/10.1002/cam4.6596Azawi, N., Mosholt, K. S. S.
, Fryd, N. D., Lund, L., Brignone, J. I., Hvid, N., Wulf-Johansson, H., Pedersen, O. B. V., Saekmose, S. G. & Dabestani, S. (2023).
suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma.
BMC Urology,
23(1), Article 168.
https://doi.org/10.1186/s12894-023-01337-zElbæk, S. K., Andreasen, T. G., Taber, A., Young-Halvorsen, K., Neijber, A.
, Jensen, J. B. & Dyrskjøt, L. (2023).
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer.
European Urology Open Science,
58, 37-46.
https://doi.org/10.1016/j.euros.2023.10.007
Wang, A., Shen, J., Rodriguez, A. A., Saunders, E. J., Chen, F., Janivara, R., Darst, B. F., Sheng, X., Xu, Y., Chou, A. J., Benlloch, S., Dadaev, T., Brook, M. N., Plym, A., Sahimi, A., Hoffman, T. J., Takahashi, A., Matsuda, K., Momozawa, Y. ... Wang, Y. (2023).
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Nature Genetics,
55(12), 2065–2074 .
https://doi.org/10.1038/s41588-023-01534-4Cai, T., Verze, P., Arcaniolo, D., Pandolfo, S. D., Smarrazzo, F., Manfredi, C., Tascini, C., Caciagli, P., Lanzafame, M., De Sio, M., Wagenlehner, F.
, Johansen, T. E. B. & Palmieri, A. (2023).
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol.
International Journal of Antimicrobial Agents,
62(5), Article 106974.
https://doi.org/10.1016/j.ijantimicag.2023.106974Hansen, E. B., Karlsson, Q., Merson, S., Wakerell, S., Rageevakumar, R.
, Jensen, J. B., Borre, M., Kote-Jarai, Z., Eeles, R. A.
& Sørensen, K. D. (2023).
Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer.
Scientific Reports,
13(1), Article 19135.
https://doi.org/10.1038/s41598-023-46323-5
Fredsøe, J. H., Glud, E. N., Boesen, L. P., Løgager, V., Poulsen, M. H.
, Pedersen, B. G., Borre, M. & Sørensen, K. D. (2023).
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP.
BMJ Open,
13(11), Article e077020.
https://doi.org/10.1136/bmjopen-2023-077020